In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

GW Pharmaceuticals closes £19mm private placement

Executive Summary

GW Pharmaceuticals PLC (develops pharmaceuticals that are derived from cannabis) netted £19mm ($31.5mm) through the sale of 9.9mm ordinary shares at £2 each ($3.30; a 13% discount to the market average price) to existing and new investors.

Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies